Document is current
Any future updates will be listed below
-
Authors
Lecornec, Nicolas https://orcid.org/0000-0001-8073-4570
Rabian, Florence https://orcid.org/0000-0002-9695-193X
Dourthe, Marie-Emilie
Chevillon, Florian
Yakouben, Karima
Chaillou, Delphine
Caillat-Zucman, Sophie
Cuffel, Alexis
Lesprit, Emmanuelle
Arnould, Anne
Naudin, Jérôme
Roupret-Serzec, Julie
Parquet, Nathalie
Brignier, Anne
Guérin-El Khourouj, Valérie
Lainey, Elodie
Caye-Eude, Aurélie https://orcid.org/0000-0001-5996-3037
Arfeuille, Chloé
Clappier, Emmanuelle
Kim, Rathana https://orcid.org/0000-0002-9987-7237
Mathis, Stéphanie
Chaix, Marie-Laure
Azoulay, Elie
Dalle, Jean-Hugues https://orcid.org/0000-0002-8406-0793
Madelaine, Isabelle
Larghero, Jérôme
Baruchel, André https://orcid.org/0000-0003-0120-6089
Boissel, Nicolas https://orcid.org/0000-0003-2091-7927
- License Information
-
More Information
Article History
Received: 4 June 2025
Revised: 6 December 2025
Accepted: 27 January 2026
First Online: 24 February 2026
Competing interests
: NB received honoraria from Novartis, Amgen, ARIAD, Astellas, Servier and Pfizer. ABaruchel received honoraria from Novartis, Servier, Jazz, and Astra-Zeneca.
